Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Caitlin Truesdale

Neuroimaging holds promise in mental health

Neuroimaging technology has been shown to hold great promise in helping clinicians link specific symptoms of mental health disorders to abnormal patterns of brain activity....

| By Caitlin Truesdale

UConn, JAX analyze brain cancer signatures

UConn Health and The Jackson Laboratory for Genomic Medicine have been collaborating on brain tumor genomic sequencing for the last five years. Most recently, they’re employing a methylome profiling...

| By Caitlin Truesdale

Jumo Health aims to increase clinical trial diversity

The FDA has issued draft guidance to help pharmaceutical companies enroll more participants from underrepresented populations into clinical trials. That’s a challenge that New Haven-based Jumo...

| By Caitlin Truesdale

The Roundup – January 5, 2023

View this email in your browser January 5, 2023 Registration for the STEM Career Expo is open! Meet hundreds of qualified students and alumni that...

| By Caitlin Truesdale

Stamford’s SpringWorks advances rare tumor drug

Stamford-based SpringWorks Therapeutics has announced the completion of the submission of its new drug application to the Food and Drug Administration for Nirogacestat, an oral medicine for...

| By Caitlin Truesdale

California biotech buys Branford’s IsoPlexis

A California bioscience company has acquired Branford’s IsoPlexis in an all-stock transaction valued at $57.8 million. Berkeley Lights, based in Emeryville, Calif., said it intends to combine...

| By Caitlin Truesdale

Quantum-Si launches ‘Platinum’ protein sequencing

Guilford-based medical technology company Quantum-Si has made its “Platinum” technology commercially available. The company said Platinum provides next-generation, single-molecule protein sequencing. The technology can be used for...

| By Caitlin Truesdale

Cybrexa appoints Needle as Chief Medical Officer

Cybrexa Therapeutics has appointed Dr. Michael N. Needle as Chief Medical Officer. A board-certified hematologist/oncologist, Dr. Needle will be responsible for overseeing and strategizing the continued...